GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Shiller PE Ratio

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Shiller PE Ratio : 29.30 (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-16), Zhejiang Jiuzhou Pharmaceutical Co's current share price is ¥15.82. Zhejiang Jiuzhou Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.54. Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio for today is 29.30.

The historical rank and industry rank for Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:603456' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.35   Med: 52.79   Max: 74.24
Current: 29.3

During the past years, Zhejiang Jiuzhou Pharmaceutical Co's highest Shiller PE Ratio was 74.24. The lowest was 27.35. And the median was 52.79.

SHSE:603456's Shiller PE Ratio is ranked worse than
58.43% of 534 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs SHSE:603456: 29.30

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Jiuzhou Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.54 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Jiuzhou Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Shiller PE Ratio Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 68.28 46.73

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.55 56.13 55.27 46.73 33.14

Competitive Comparison of Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio falls into.



Zhejiang Jiuzhou Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=15.82/0.54
=29.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Jiuzhou Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Zhejiang Jiuzhou Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.26/114.6694*114.6694
=0.260

Current CPI (Mar. 2024) = 114.6694.

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.078 98.200 0.091
201409 0.058 98.900 0.067
201412 0.028 99.000 0.032
201503 0.056 99.900 0.064
201506 0.095 99.500 0.109
201509 0.150 100.500 0.171
201512 0.039 100.600 0.044
201603 0.050 102.200 0.056
201606 0.000 101.400 0.000
201609 0.061 102.400 0.068
201612 0.033 102.600 0.037
201703 0.056 103.200 0.062
201706 0.034 103.100 0.038
201709 0.050 104.100 0.055
201712 0.040 104.500 0.044
201803 0.060 105.300 0.065
201806 0.050 104.900 0.055
201809 0.010 106.600 0.011
201812 0.080 106.500 0.086
201903 0.050 107.700 0.053
201906 0.080 107.700 0.085
201909 0.040 109.800 0.042
201912 0.130 111.200 0.134
202003 0.040 112.300 0.041
202006 0.120 110.400 0.125
202009 0.140 111.700 0.144
202012 0.170 111.500 0.175
202103 0.110 112.662 0.112
202106 0.220 111.769 0.226
202109 0.240 112.215 0.245
202112 0.190 113.108 0.193
202203 0.250 114.335 0.251
202206 0.310 114.558 0.310
202209 0.330 115.339 0.328
202212 0.210 115.116 0.209
202303 0.320 115.116 0.319
202306 0.380 114.558 0.380
202309 0.390 115.339 0.388
202312 0.070 114.669 0.070
202403 0.260 114.669 0.260

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Jiuzhou Pharmaceutical Co  (SHSE:603456) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhejiang Jiuzhou Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Traded in Other Exchanges
N/A
Address
99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines